Journal profile · SUBSTANCE ABUSE
Heroin Addiction and Related Clinical Problems
ISSN 1592-1638 · Pacini Editore SpA
Heroin Addiction and Related Clinical Problems: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.55; subscription journal; APC charged, amount not published; 33 articles in 2025; indexed in SSCI and Scopus.
Scope
Aims, scope and focus
Heroin Addiction and Related Clinical Problems is published by Pacini Editore SpA and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes and Pain Management and Opioid Use, together about 46.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Heroin Addiction and Related Clinical Problems publishes Editorials, Regular Articles, Short Reviews, Reviews, Preliminary Communications, Short Communications, Reports, Expert Opinions, Case Reports, and Letters to the Editor on subjects regarding heroin addiction and related clinical problems. Heroin Addiction and Related Clinical Problems is particularly interested in therapies, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses. Reviews should include systematic literature revision concerning the topics treated and meta-analyses. Short reviews are dedicated to particular aspects of heroin addiction. Heroin Addiction and Related Clinical Problems accepts for publication only unpublished data. The structured abstract must not exceed 300 words.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE
Main research topics OpenAlex counts of recent articles; shares are approximate
- Opioid Use Disorder TreatmentMedicine21.5%
- Substance Abuse Treatment and OutcomesMedicine17.2%
- Pain Management and Opioid UseMedicine7.9%
- HIV, Drug Use, Sexual RiskMedicine5.7%
- Prenatal Substance Exposure EffectsMedicine4.3%
- Mental Health Treatment and AccessPsychology3.9%
- Treatment of Major DepressionMedicine3.9%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
Database indexing
SSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.55LetPub ·
- Impact factor (publisher) 2025
- 0.6Publisher website ·
- 5-year impact factor (publisher)
- 0.5Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 8OpenAlex ·
- i10-index
- 7OpenAlex ·
- 2-year mean citedness
- 0.86OpenAlex ·
- Self-citation rate
- 66.7%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 31LetPub ·
Articles by year OpenAlex count · 135 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 5 | 0 | 0 |
| 2025 | 33 | 2 | 18 |
| 2024 | 65 | 6 | 71 |
| 2021 | 3 | 0 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Peer review
- Authorship Authorship
Each author must fulfil the following criteria: They must have contributed substantially to research design or data acquisition, analysis, or interpretation. They must have drafted the paper or revised it critically. They must have approved the submitted and final versions. Copyright Transfer Agreement: Heroin Addiction and Related Clinical Problems: Authors must NOT sign a copyright declaration. …
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
Sources of financial support during the last two years must be acknowledged. Please read the following statements, adding relevant sections at the end of your submitted manuscript under the heading ‘Conflict of interest. Some examples are: The authors declared no conflict of interest. [Name of individual] has served as a speaker, a consultant, and an advisory board member for [names of organisatio…
Source ↗Publisher website ·- Peer review Peer Review Process
All submitted manuscripts undergo an internal editorial review to assess their originality, scientific merit, methodological soundness, and relevance to the aims and scope of Heroin Addiction and Related Clinical Problems. The journal follows a single-blind peer review process. The evaluation is conducted primarily by members of the editorial staff with the help of reviewers who are experts in the…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pacini Editore SpA
- ISSN
- 1592-1638
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Heroin Addiction and Related Clinical Problems
What CAS zone is Heroin Addiction and Related Clinical Problems in?
In the 2025 upgraded edition of the CAS Journal Ranking, Heroin Addiction and Related Clinical Problems is in Zone 4 of Medicine, and in Zone 4 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Heroin Addiction and Related Clinical Problems?
The latest impact factor listed by LetPub is 0.55; CiteScore 1.8, h-index 8.
Which databases index Heroin Addiction and Related Clinical Problems?
According to LetPub and DOAJ records, Heroin Addiction and Related Clinical Problems is indexed in SSCI and Scopus.
Is Heroin Addiction and Related Clinical Problems open access, and what is the APC?
Heroin Addiction and Related Clinical Problems is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .